VIR BIOTECHNOLOGY, INC. for VIR BIOTECHNOLOGY, INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Pandemic Preparedness Funding, Influenza Preparedness; COVID-19 Response and Therapeutics Procurement and Distribution; FY 2024 Labor-HHS Appropriations; Pandemic and All-Hazards Preparedness Act Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| DOUGLAS STOSS | — |
Science/Technology SCI
Pandemic Preparedness; Biomanufacturing
| Lobbyist | Covered position, as disclosed |
|---|---|
| DOUGLAS STOSS | — |
Medicare/Medicaid MMM
Inflation Reduction Act Rx Provisions Implementation
| Lobbyist | Covered position, as disclosed |
|---|---|
| DOUGLAS STOSS | — |
Taxation/Internal Revenue Code TAX
S. 866, American Innovation and Jobs Act; H.R. 2673, American Innovation and R&D Competitiveness Act; H.R. 3938, Build It In America Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DOUGLAS STOSS | — |
Trade (domestic/foreign) TRD
COVID-19 Trade Related Aspects of Intellectual Property Rights Waiver
| Lobbyist | Covered position, as disclosed |
|---|---|
| DOUGLAS STOSS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.